ASEAN KEY DESTINATIONS
Mega seeks home, Myanmar growth
SET-listed Mega Lifesciences Plc, the pharmaceutical and herbal medicine manufacturer, will allocate 820 million baht to expand its business in Thailand and Myanmar this year in search of long-term sustainable growth.
Of the total, 120 million baht will be invested in a new wellness centre in MuakLek district of Saraburi and 160 million will be used to buy 17.2 rai next to its factory at Bangpoo Industrial Estate in Samut Prakan, said chief executive Vivek Dhawan.
The land will be used to increase manufacturing and storage capacity in the near future.
The remaining 540 million baht will be spent on building a distribution centre in Yangon, Myanmar, in the next two years. The 25-rai facility will have 12,000 to 15,000 square metres of space.
"The additional investment in Myanmar will be made because almost one-third of our revenue comes from the neighbouring country," Mr Dhawan said.
Mega's wellness centre in MuakLek is due to open in the fourth quarter of this year. The clinic will have a concept of preventing and reversing disease naturally.
"This is an exciting development and a new incubator business for us," Mr Dhawan said, adding that this is the first clinic in Thailand to use nutrition as a primary medicine.
"We eat food every day, so why shouldn't we use it to heal our illnesses also? The clinic will focus on non-communicable diseases such as heart disease and diabetes," he said.
The world is changing and becoming more interested in natural health and Thailand is the perfect location for such a unique concept, he said.
"Thailand has wonderful fresh food, a strong history of using traditional herbs and plentiful natural resources. We can see Thailand as a worldwide hub of this kind of approach to preventing and reversing disease," Mr Dhawan said.
Mega chose to start with this business approach because there is growing demand for natural cures for illness around the world as people look for alternative treatments.
It will change its marketing mix to increase knowledge for consumers so that they know how to use supplements in the right way. The company will focus on herbal and natural medicines and launch new products in Thailand.
Mega aims to grow its revenue this year by 5-10% from 7.94 billion baht last year, of which 3.2 billion baht came from overseas.
It aims to double its size by 2020 by growing its business, launching new products and expanding to new countries.
Mega now does business in 31 countries in Southeast Asia, Africa, Latin America and the Commonwealth of Independent States. Southeast Asia and Africa provide 93% of foreign revenue.
MEGA shares closed on Tuesday on the Stock Exchange of Thailand (SET) at 17.20 baht, up 20 satang, in trade worth 7.8 million baht.--mizzima
Letters that do not contain full contact information cannot be published.
Letters become the property of AseanAffairs and may be republished in any format.
They typically run 150 words or less and may be edited
submit your comment in the box below